DAFTAR PUSTAKA 18 27 - etd.repository.ugm.ac.id

DAFTAR PUSTAKA

Aamir, M., Khan, J.A., Shakeel, F., Shareef, R., dan Shah, N., 2018. Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing. BMC Pediatrics, 18:242-250 .

Agrawal, R.P., Goswami, J., Jain, S., dan Kochar, D.K., 2009. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study. Diabetes Research and Clinical Practice, 83: 371–378.

Ambrósio, A.F., Soares-Da-Silva, P., Carvalho, C.M., dan Carvalho, A.P., 2002. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochemical Research, 27: 121–130.

Andayani, T. M., 2013, Farmakoekonomi, Prinsip dan Metodologi, Bursa Ilmu, Yogyakarta

Arora, M., Agarwal, A., Baidya, D., dan Khanna, P., 2011. Pregabalin in acute and chronic pain. Journal of Anaesthesiology Clinical Pharmacology, 27: 307-314.

Athanasakis, K., Petrakis, I., Karampli, E., Vitsou, E., Lyras, L., dan Kyriopoulos, J., 2013. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. BMC neurology, 13: 56-63.

Baron, R., Binder, A., dan Wasner, G., 2010. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. The Lancet Neurology, 9: 807–819.

Basbaum, A.I., Bautista, D.M., Scherrer, G., dan Julius, D., 2009. Cellular and Molecular Mechanisms of Pain. Cell, 139: 267–284.

Bashir, A.H., Abdullahi, A., Abba, M.A., dan Mukhtar, N.B., 2017. Central Poststroke Pain: Its Profile among Stroke Survivors in Kano, Nigeria. Behavioural Neurology, 2017.

Berlin, R.K., Butler, P.M., dan Perloff, M.D., 2015. Gabapentin Therapy in Psychiatric Disorders: A Systematic Review. The Primary Care Companion for CNS Disorders, 17(5):1-28 .

Birse, F., Derry, S., dan Moore, R.A., 2012. Phenytoin for neuropathic pain and fibromyalgia in adults, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Bockbrader, H.N., Wesche, D., Miller, R., Chapel, S., Janiczek, N., dan Burger, P., 2010. A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin: Clinical Pharmacokinetics, 49: 661–669.

131

KAJIAN RISIKO - MANFAAT PENGGUNAAN ANTIKONVULSAN SECARA OFF-LABEL PADA TERAPINYERI NEUROPATISENTRAL POST STROKE STUDI PADA PREGABALIN dan GABAPENTIN BANGUNAWATI RAHAJENG, Prof. Dr. Zullies Ikawati.,Apt; Dr. Tri Murti Andayani., SpFRS., Apt; Prof.dr Iwan Dwiprahasto., M.Med.Sc., PhDUniversitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Bootman, J.L., Townsend, R.J., dan McGhan, W.F., 2005, Principles of

Pharmacoeconomics. 3rd

Ed. Havard Whitney Books Company, Cincinnati.

Breivik, H., Borchgrevink, P.C., Allen, S.M., Rosseland, L.A., Romundstad, L., Breivik Hals, E.K., dkk., 2008. Assessment of pain. British Journal of Anaesthesia, 101: 17–24.

Cellini, S.R. dan Kee, J.E., 2010. Cost-effectiveness and cost-benefit analysis.

Handbook of practical program evaluation,21: 493-530 .

Chen, H., Deshpande, A.D., Jiang, R., dan Martin, B.C., 2005. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiology and Drug Safety, 14: 629–638.

Chen, H., Reeves, J.H., Fincham, J.E., Kennedy, W.K., dan Martin, B.C., 2006. Off-Label Use of Antidepressant, Anticonvulsant, and Antipsychotic Medications Among Georgia Medicaid Enrollees in 2001. The Journal of Clinical Psychiatry, 67: 1,478-982.

Choonara, I. dan Conroy, S., 2002. Unlicensed and off-label drug use in children:

implications for safety. - PubMed - NCBI. Drug Safety, 25: 1–5.

Clarke, H., Kay, J., Orser, B.A., Gollish, J., Mitsakakis, N., dan Katz, J., 2010. Gabapentin Does Not Reduce Preoperative Anxiety When Given Prior to Total Hip Arthroplasty. Pain Medicine, 11: 966–971.

Cross, A.L. dan Sherman, A. l, 2017. Pregabalin, dalam: StatPearls. StatPearls Publishing, Treasure Island (FL).

Dahlan, M.S, 2010. Besar Sampel dan Cara Pengambilan Sampel. Seri 2. Salemba Medika, Jakarta.

Danés, I., Agustí, A., Vallano, A., Alerany, C., Martínez, J., Bosch, J.A., dkk., 2014. Outcomes of off-label drug uses in hospitals: a multicentric prospective study. European Journal of Clinical Pharmacology, 70: 1385– 1393.

Dasgupta, A., 2012. Therapeutic Drug Monitoring: Newer Drugs and Biomarkers. Academic Press.

Davis, L.L., Bartolucci, A., dan Petty, F., 2005. Divalproex in the treatment of bipolar depression: a placebo-controlled study. Journal of Affective Disorders, 85: 259–266.

Defrin, R., Eli, I., dan Pud, D., 2011. Interactions Among Sex, Ethnicity, Religion, and Gender Role Expectations of Pain. Gender Medicine, 8: 172–183.

Defrin, R., Shramm, L., dan Eli, I., 2009. Gender role expectations of pain is associated with pain tolerance limit but not with pain threshold: Pain, 145: 230–236.

132


Dworkin, R.H., Turk, D.C., Wyrwich, K.W., Beaton, D., Cleeland, C.S., Farrar, J.T., dkk., 2008. Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations.

The Journal of Pain, 9: 105–121.

Ebell, M.H., Siwek, J., Weiss, B.D., Woolf, S.H., Susman, J., Ewigman, B., dkk.,

2004. Strength of Recommendation Taxonomy (SORT): A Patient-Centered Approach to Grading Evidence in the Medical Literature. The

Journal of the American Board of Family Medicine, 17: 59–67.

Ferreira, L. de A., Ibiapina, C. da C., Machado, M.G.P., dan Fagundes, E.D.T., 2012. High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit. Revista da Associação Médica Brasileira

(English Edition), 58: 82–87.

Finnerup, N.B. dan Jensen, T.S., 2007. Clinical use of pregabalin in the management of central neuropathic pain. Neuropsychiatric disease and treatment, 3: 885-891.

Franco, V., Canevini, M.P., Capovilla, G., De Sarro, G., Galimberti, C.A., Gatti, G., dkk., 2014. Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of

Tertiary Care Centers in Italy. CNS Drugs, 28: 939–949.

Gazarian, M., 2007. 'Off ‐ Label Use Of Medicines In The Paediatric Poulation:

Recommendations For Assesing Appropriateness'. NSW, 2031, Sydney,

Australia.

Ghaemi, S.N., Gilmer, W.S., Goldberg, J.F., Zablotsky, B., Kemp, D.E., Kelley, M.E., dkk., 2007. Divalproex in the treatment of acute bipolar depression: A preliminary double-blind, randomized, placebo-controlled pilot study.

Journal of Clinical Psychiatry, 68: 1840–1844.

Gill, D., Derry, S., Wiffen, P.J., dan Moore, R.A., 2011. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Gilron, I., Wajsbrot, D., Therrien, F., dan Lemay, J., 2011. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial. The Clinical Journal of

Pain, 27: 185–193.

Gilron, I., Watson, C.P.N., Cahill, C.M., dan Moulin, D.E., 2006. Neuropathic pain: a practical guide for the clinician. Canadian Medical Association

Journal, 175: 265–275.

Gloth, F.M., 2001. Pain management in older adults: prevention and treatment.

Journal of the American Geriatrics Society, 49: 188–199.

Gómez-Pérez, F.J., Choza, R., Ríos, J.M., Reza, A., Huerta, E., Aguilar, C.A., dkk., 1996. Nortriptyline-fluphenazine vs. carbamazepine in the

133


symptomatic treatment of diabetic neuropathy. Archives of Medical Research, 27: 525–529.

Groleger, U., 2007. Off-label use of antipsychotics: rethinking ―off-label.‖

Psychiatria Danubina, 19: 350–353.

Harno, H., Haapaniemi, E., Putaala, J., Haanpaa, M., Makela, J.P., Kalso, E., dkk., 2014. Central poststroke pain in young ischemic stroke survivors in the Helsinki Young Stroke Registry. Neurology, 83: 1147–1154.

Hawker, G.A., Mian, S., Kendzerska, T., dan French, M., 2011. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for

Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF. Arthritis Care & Research, 63: S240–

S252.

Henningsen, P., 2018. Management of somatic symptom disorder. Dialogues in Clinical Neuroscience, 20: 23-31.

Horen, B., Montastruc, J.-L., dan Lapeyre-mestre, M., 2002. Adverse drug reactions and off-label drug use in paediatric outpatients. British Journal of Clinical Pharmacology, 54: 665–670.

Horowitz, E., Bergman, L.C., Ashkenazy, C., Moscona-Hurvitz, I., Grinvald-Fogel, H., dan Magnezi, R., 2014. Off-Label Use of Sodium Valproate for Schizophrenia. PLoS ONE, 9: e92573.

Ikatan Apoteker Indonesia, 2014. SK PO-001 ttg PO Standar Praktik Apoteker Indonesia.pdf.

Javangula, H., 2012. AN OVERVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH.

Jay, G.W. dan Barkin, R.L., 2014. Neuropathic pain: Etiology, pathophysiology,

mechanisms, and evaluations. Disease-a-Month, 60: 6–47.

Jensen, T.S., 2002. Anticonvulsants in neuropathic pain: rationale and clinical

evidence. European Journal of Pain, 6: 61–68.

Jia, H., Li, Q., Song, D., An, Z., Liu, Y., Ran, X., dkk., 2006. Effects of Veniafaxine and Carbamazepine for Painful Peripheral Diabetic

Neuropathy ： A Randomized ， Double-blind and Double- dummy,

Controlled Multi-center Trial. Chinese Journal of Evidence Based

Medicine, 6: 321–7.

Jonsson, A.-C., Lindgren, I., Hallstrom, B., dan Lindgren, A., 2006. Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. Journal of Neurology, Neurosurgery & Psychiatry,

77: 590–595.

Kasper, S., Herman, B., Nivoli, G., Ameringen, M.V., Petralia, A., Mandel, F.S., dkk., 2009. Efficacy of pregabalin and venlafaxine-XR in generalized

134


anxiety disorder: results of a double-blind, placebo-controlled 8-week

trial: International Clinical Psychopharmacology, 24: 87–96.

Kaufman, K.R., 2011. Antiepileptic drugs in the treatment of psychiatric disorders.

Epilepsy & Behavior, 21: 1–11.

Kaydok, E., Levendoglu, F., Ozerbil, M.O., dan Karahan, A.Y., 2014. Comparison

of The Efficacy of Gabapentin and Pregabalin For Neurophatic Pain In Patients With Spinal Cord Injury : A Crossover Study. Acta Medica, 30: 1343.

Khetarpal, R., Kataria, A., Bajaj, S., Kaur, H., dan Singh, S., 2016. Gabapentin vs pregabalin as a premedication in lower limb orthopaedics surgery under combined spinal epidural technique. Anesthesia: Essays and Researches, 10: 262.

Kim, J.S., Bashford, G., Murphy, K.T., Martin, A., Dror, V., dan Cheung, R., 2011. Safety and efficacy of pregabalin in patients with central post-stroke pain: Pain, 152: 1018–1023.

Klit, H., Finnerup, N.B., dan Jensen, T.S., 2009. Central post-stroke pain: clinical characteristics, pathophysiology, and management. The Lancet Neurology, 8: 857–868.

Klit, H.M., Finnerup, N.B., dan Jensen, T.S., 2015. Diagnosis, Prevalence Characteristics and Treatment of Central Poststroke Pain. International Association for the Study of Pain, 12: 1–7.

Knopf, H., Wolf, I.-K., Sarganas, G., Zhuang, W., Rascher, W., dan Neubert, A., 2013. Off-label medicine use in children and adolescents: results of a population-based study in Germany. BMC Public Health, 13: 631.

Kochar, D.K., Garg, P., Bumb, R.A., Kochar, S.K., Mehta, R.D., Beniwal, R., dkk., 2005. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM, 98: 29–34.

Kochar, D.K., Rawat, N., Agrawal, R.P., Vyas, A., Beniwal, R., Kochar, S.K., dkk., 2004. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM: An International Journal of Medicine, 97: 33–38.

Krasowski, M.D., 2010. Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals, 3: 1909–1935.

Landmark, C.J., 2008. Antiepileptic drugs in non-epilepsy disorders. CNS drugs, 22: 27–47.

Lavigne, J.E., Heckler, C., Mathews, J.L., Palesh, O., Kirshner, J.J., Lord, R., dkk.,

2012. A randomized, controlled, double-blinded clinical trial of gabapentin

300 versus 900 mg versus placebo for anxiety symptoms in breast cancer

survivors. Breast Cancer Research and Treatment, 136: 479–486.

135


Le Jeunne, C., Billon, N., Dandon, A., participants of round table N° 3 of Giens XXVIII:, Berdaï, D., Adgibi, Y., dkk., 2013. Off-label Prescriptions: how to Identify Them, Frame Them, Announce Them and Monitor Them in Practice? Thérapie, 68: 233–239.

Lee, J.-H., Byon, H.-J., Choi, S., Jang, Y.-E., Kim, E.-H., Kim, J.-T., dkk., 2018.

Safety and Efficacy of Off-label and Unlicensed Medicines in Children.

Journal of Korean Medical Science, 33: 1-10.

Leijon, G. dan Boivie, J., 1989. Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain, 36: 27–36.

Lenk, C. dan Duttge, G., 2014. Ethical and legal framework and regulation for off-label use: European perspective. Therapeutics and Clinical Risk Management, 537.

Li, L., Liu, X., dan Herr, K., 2007. Postoperative pain intensity assessment: a comparison of four scales in Chinese adults. Pain Medicine (Malden, Mass.), 8: 223–234.

Liu, B., Liu, R., dan Wang, L., 2017. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery: Medicine, 96: e8031.

Lydiard, R.B., 2003. The role of GABA in anxiety disorders. The Journal of Clinical Psychiatry, 64 Suppl 3: 21–27.

Maheshwary, N., Saeed, T., Nasrullah, M., Ghafoor, A., Shahid, R., Islam, N., dkk., 2014. Efficacy and tolerability of carbamazepine for the treatment of painful diabetic neuropathy in adults: a 12-week, open-label, multicenter study. International Journal of General Medicine, 339.

Mazhar, F., Akram, S., Haider, N., Hadi, M.A., dan Sultana, J., 2018. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study. International Journal of Clinical Pharmacy, .

McCleane, G.J., 1999. Intravenous Infusion of Phenytoin Relieves Neuropathic Pain: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study. Anesth Analg, 89: 985–8.

Ménigaux, C., Adam, F., Guignard, B., Sessler, D.I., dan Chauvin, M., 2005. Preoperative Gabapentin Decreases Anxiety and Improves Early Functional Recovery from Knee Surgery: Anesthesia & Analgesia, 100: 1394–1399.

Minella, C., Raffaeli, W., Magnani, F., dan Sarti, 2013. Population-based study of central post-stroke pain in Rimini district, Italy. Journal of Pain Research, 705.

Mishra, R., Tripathi, M., dan Chandola, H., 2016. Comparative clinical study of gabapentin and pregabalin for postoperative analgesia in laparoscopic cholecystectomy. Anesthesia: Essays and Researches, 10: 201.

136


Monasterio, E. dan McKean, A., 2011. Off-label use of atypical antipsychotic medications in Canterbury, New Zealand. NZ Med J, 124: 24–9.

Moore, R.A., Straube, S., Wiffen, P.J., Derry, S., dan McQuay, H.J., 2009. Pregabalin for acute and chronic pain in adults, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Moore, R.A., Wiffen, P.J., Derry, S., Toelle, T., dan Rice, A.S.C., 2014. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. The Cochrane Database of Systematic Reviews, 4: CD007938.

Nemeroff, C.B., 2003. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacology Bulletin, 37: 133–146.

O’Connor, A.B., Noyes, K., dan Holloway, R.G., 2007. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. Journal of the American Geriatrics Society, 55: 1176–1184.

Oks, M., Cleven, K.L., Healy, L., Wei, M., Narasimhan, M., Mayo, P.H., dkk., 2018. The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit. Journal of Intensive Care Medicine, 088506661878394.

Onouchi, K., Yokoyama, K., Yoshiyama, T., dan Koga, H., 2014. An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. Journal of Pain Research, 439.

Onyenwenyi, A.J., 2008. 'Off-Label Prescribing of Anticonvulsant Drugs', Desertasi, . University of Florida, Florida, United States.

Pande, A.C., Feltner, D.E., Jefferson, J.W., Davidson, J.R.T., Pollack, M., Stein, M.B., dkk., 2004. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24: 141–149.

Pratiwi, A.A., Khairinnisa, M.A., Alfian, S.D., Priyadi, A., Pradipta, I.S., dan Abdulah, R., 2013. Peresepan Obat-obat Off-Label pada Pasien Anak Usia 0 Hingga 2 Tahun di Apotek Kota Bandung. Jurnal Farmasi Klinik Indonesia, 2: 39–50.

Radley, D.C., Finkelstein, S.N., dan Stafford, R.S., 2006. Off-label prescribing among office-based physicians. Archives of Internal Medicine, 166: 1021– 1026.

Raja, M. dan Azzoni, A., 2003. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. The International Journal of Neuropsychopharmacology, 6: 409–414.

Reeder, C.E., 1995. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations. American journal of health-system pharmacy:

137


AJHP: official journal of the American Society of Health-System

Pharmacists, 52: S5-8.

Rodríguez, M.J., Díaz, S., Vera-Llonch, M., Dukes, E., dan Rejas, J., 2007. Cost-

effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. Current Medical Research and Opinion, 23: 2585–2596.

Rose, M.A. dan Kam, P.C.A., 2002. Gabapentin: pharmacology and its use in pain

management. Anaesthesia, 57: 451–462.

Sachs, J. dan Weltgesundheitsorganisation (Eds.), 2001. Macroeconomics and Health: Investing in Health for Economic Development ; Report of the Commission on Macroeconomics and Health. World Health Organization, Geneva.

Sazgar, M. dan Bourgeois, B.F.D., 2005. Aggravation of Epilepsy By Antiepileptic Drugs. Pediatric Neurology, 33: 227–234.

Schifano, F., 2014. Misuse and Abuse of Pregabalin and Gabapentin: Cause for

Concern? CNS Drugs, 28: 491–496.

Semel, D., Murphy, T.K., Zlateva, G., Cheung, R., dan Emir, B., 2010. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC family practice, 11: 85.

Shneker, B.F. dan McAuley, J.W., 2005. Pregabalin: a new neuromodulator with broad therapeutic indications. The Annals of Pharmacotherapy, 39: 2029– 2037.

Sicras-Mainar, A., Rejas-Gutiérrez, J., Navarro-Artieda, R., dan Planas-Comes, A., 2012. Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain: Pregabalin and gabapentin in neuropathic pain. Journal of Evaluation in Clinical Practice, 18: 1170–1179.

Siddall, P.J., Cousins, M.J., Otte, A., Griesing, T., Chambers, R., dan Murphy, T.K., 2006. Pregabalin in central neuropathic CME pain associated with spinal cord injury. Neurology, 67: 1792–800.

Singla, Chelly, J., Lionberger, D., Gimbel, J., Sanin, L., Sporn, J., dkk., 2014. Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models. Journal of Pain Research, 9.

Sjölund, K.-F., Yang, R., Lee, K.-H., dan Resnick, M., 2013. Randomized Study of Pregabalin in Patients with Cancer-Induced Bone Pain. Pain and Therapy, 2: 37–48.

Smith, L.A., Cornelius, V.R., Azorin, J.M., Perugi, G., Vieta, E., Young, A.H., dkk., 2010. Valproate for the treatment of acute bipolar depression:

138


Systematic review and meta-analysis. Journal of Affective Disorders, 122:

1–9.

Snedecor, S., Sudharshan, L., Cappelleri, Sadosky, A., Desai, Jalundhwala, dkk.,

2013. Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury. Journal of Pain Research, 539.

Spina, E. dan Perugi, G., 2004. Antiepileptic drugs indications other than epilepsy.

Epileptic Dissorder, 6: 57–75.

Stafford, R.S., 2008. Regulating Off-Label Drug Use — Rethinking the Role of the FDA. The New England Journal of Medicine, , 14 358: 1427–1429.

Tarride, J.-E., Gordon, A., Vera-Llonch, M., Dukes, E., dan Rousseau, C., 2006. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective. Clinical Therapeutics, 28: 1922–1934.

Toth, C., 2013. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Therapeutic advances in drug safety, 2042098613505614.

Tracy Glauser, Elinor Ben-Menachem, Blaise Bourgeois, Avital Cnaan, Carlos Guerreiro, Reetta Ka, dkk., 2013. Guidelines-epilepsia-12074-2013.pdf. Epilepsia, 1–13.

Tran, A.R., Zito, J.M., Safer, D.J., dan Hundley, S.D., 2014. National trends in pediatric use of anticonvulsants.

Tzellos, T.G., Toulis, K.A., Goulis, D.G., Papazisis, G., Zampeli, V.A., Vakfari, A., dkk., 2010. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 35: 639–656.

Vargas-Espinosa, M., Sanmarti-Garcia, G., Vazquez-Delgado, E., dan Gay-

Escoda, C., 2012. Antiepileptic drugs for the treatment of neuropathic

pain: A systematic review. Medicina Oral Patología Oral y Cirugia Bucal,

e786–e793.

Ventola, C.L., 2009. Off-label drug information: Regulation, distribution, evaluation, and related controversies. Pharmacy and Therapeutics, 34: 428-449.

Vinik, A., Emir, B., Cheung, R., dan Whalen, E., 2013. Relationship Between Pain Relief and Improvements in Patient Function/Quality of Life in Patients With Painful Diabetic Peripheral Neuropathy or Postherpetic

Neuralgia Treated With Pregabalin. Clinical Therapeutics, 35: 612–623.

Vogenberg, F.R., 2001. Introduction to Pharmacoeconomics. McGraw-Hill, New York; London.

139


Vranken, J., Dijkgraaf, M., van der Vegt, M., Hollman, M., dan Hessen, M., 2008. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. - PubMed - NCBI. Pain, 136: 150–7.

Vranken, J.H., Dijkgraaf, M.G.W., Kruis, M.R., van der Vegt, M.H., Hollmann, M.W., dan Heesen, M., 2008. Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen: Pain, 136: 150–157.

Wallach, J.D. dan Ross, J.S., 2018. Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts. JAMA, 319: 776-778.

Walley, T., Haycox, A., Boland, A., dan Breckenridge, A.M., 2004.

Pharmacoeconomics.

Wandner, L.D., Scipio, C.D., Hirsh, A.T., Torres, C.A., dan Robinson, M.E., 2012. The Perception of Pain in Others: How Gender, Race, and Age Influence Pain Expectations. The Journal of Pain, 13: 220–227.

Wesolowicz, D., Clark, J., Boissoneault, J., dan Robinson, M., 2018. The roles of gender and profession on gender role expectations of pain in health care professionals. Journal of Pain Research, Volume 11: 1121–1128.

Wiffen, P.J., Derry, S., Bell, R.F., Rice, A.S., Tölle, T.R., Phillips, T., dkk., 2017. Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, .

Wiffen, P.J., Derry, S., Moore, R.A., Aldington, D., Cole, P., Rice, A.S.C., dkk., 2013. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Wiffen, P.J., Derry, S., Moore, R.A., dan Kalso, E.A., 2014. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Wiffen, P.J., Derry, S., Moore, R.A., dan McQuay, H.J., 2011. Carbamazepine for acute and chronic pain in adults, dalam: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Wittich, C.M., Burkle, C.M., dan Lanier, W.L., 2012. Ten Common Questions (and Their Answers) About Off-label Drug Use. Mayo Clinic Proceedings, 87: 982–990.

Zaccara, G., Gangemi, P., Perucca, P., dan Specchio, L., 2011. The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials: Meta-Analysis of Pregabalin Adverse Effects. Epilepsia, 52: 826–836.

140


Zaccara, G., Perucca, P., dan Gangemi, P.F., 2012. The adverse event profile of pregabalin across different disorders: a meta-analysis. European Journal of Clinical Pharmacology, 68: 903–912.

141


Documents

DAFTAR PUSTAKA 18 27 - etd.repository.ugm.ac.id